{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:25:10Z","timestamp":1783340710895,"version":"3.54.6"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pediatric thrombosis is a relatively rare but severe condition in the field of pediatrics, with far-reaching consequences. Recent studies have indicated a rising incidence of this disease in children over the years. Additionally, the pharmacological treatment of thrombotic diseases in children faces numerous challenges. Due to significant physiological differences between children and adults, guidelines for the prevention and treatment of thrombotic diseases in adults cannot be directly applied to pediatric patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Purpose<\/jats:title><jats:p>A systematic review of the existing evidence-based medical literature should be conducted to propose pharmacological prevention and treatment recommendations for pediatric thrombotic diseases. Developing a comprehensive and practical pharmacotherapy guideline for the prevention and treatment of pediatric thrombotic diseases is essential to enhancing the rational use of medications in managing these conditions in children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The guideline development followed the World Health Organization's (WHO) Handbook for Guideline Development. This involves systematically searching and extensively collecting data on common medication issues in the prevention and treatment of pediatric thrombosis nationwide. The Delphi method was used to survey experts and identify the clinical issues to be included. Subsequently, a systematic literature review was conducted to evaluate existing primary studies, systematic reviews, and guidelines or consensus statements from professional organizations. The quality of the evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. The Delphi method was employed again to reach a consensus on the recommendations and evidence levels. This process was culminated in the development of the Guideline for Pharmacological Management of Thrombotic Diseases in Children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During the guideline development process, a total of 29 clinical issues were collected and evaluated by 78 experts in clinical pharmacy and clinical medicine. Through two rounds of surveys, 13 clinical issues were selected. Under the supervision of two methodologists, 13 clinical pharmacotherapy recommendations were formulated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>By conducting a comprehensive assessment of the feasibility and safety of clinical practices, the guideline provides specific anticoagulant medication recommendations for pediatric healthcare professionals. This will help enhance the prevention and treatment of pediatric thrombosis, promoting more standardized and effective medical practices.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1519517","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T07:14:02Z","timestamp":1737530042000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Addressing challenges in pediatric thrombosis: a comprehensive guideline development"],"prefix":"10.3389","volume":"13","author":[{"given":"Yin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Die","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiadan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"key":"B2","first-page":"OC422","article-title":"Thromboembolism in childhood: a prospective two year BPSU study in the United Kingdom. February 2001\u2013February 2003","volume":"1","author":"Gibson","year":"2004","journal-title":"Br J Haematol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1007\/s00464-011-1927-3","article-title":"Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy","volume":"25","author":"Pearl","year":"2011","journal-title":"Surg Endosc"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","article-title":"American society of hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","volume":"2","author":"Monagle","year":"2018","journal-title":"Blood Adv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1182\/blood.2019001847","article-title":"Treatment of venous thromboembolism in pediatric patients","volume":"135","author":"Witmer","year":"2020","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1542\/peds.2009-0768","article-title":"Dramatic increase in venous thromboembolism in children\u2019s hospitals in the United States from 2001 to 2007","volume":"124","author":"Raffini","year":"2009","journal-title":"Pediatrics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jpeds.2011.03.052","article-title":"Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study","volume":"159","author":"Tuckuviene","year":"2011","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12098-018-2827-5","article-title":"Pediatric thrombotic events: incidence, clinical risk factors and outcome","volume":"86","author":"Gupta","year":"2019","journal-title":"Indian J Pediatr"},{"key":"B9","first-page":"270","article-title":"Advances in rivaroxaban in thromboembolic disease in children","volume":"56","author":"Wei","year":"2021","journal-title":"Chin J Pharm"},{"key":"B10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1182\/asheducation-2018.1.399","article-title":"Management of thrombosis in children and neonates: practical use of anticoagulants in children","volume":"2018","author":"Monagle","year":"2018","journal-title":"Hematology"},{"key":"B11","first-page":"571","article-title":"Antithrombotic therapy and prevention of thrombosis (9 ed.): American college of chest physicians evidence-based clinical practice guidelines (abridged and organized edition)","volume":"7","author":"Dongchao","year":"2012","journal-title":"Chin J Stroke"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e63715","DOI":"10.1371\/journal.pone.0063715","article-title":"World health organization guideline development: an evaluation","volume":"8","author":"Sinclair","year":"2013","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.jclinepi.2010.07.001","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"63","author":"Brouwers","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7326\/M16-1565","article-title":"A reporting tool for practice guidelines in health care: the RIGHT statement","volume":"166","author":"Chen","year":"2017","journal-title":"Ann Intern Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B17","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2020"},{"key":"B18","article-title":"Appendix 4 quality of case series form 2015","year":"2015"},{"key":"B19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B20","first-page":"25","volume-title":"Evidence-Based Clinical Practice Guideline Development and Implementation","author":"Wang","year":"2016"},{"key":"B21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jpeds.2004.06.021","article-title":"Incidence of venous thromboembolism in infants and children: data from the national hospital discharge survey","volume":"145","author":"Stein","year":"2004","journal-title":"J Pediatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/BPB.0000000000000053","article-title":"Risk factors for venous thromboembolism in hospitalized children and adolescents","volume":"23","author":"Kim","year":"2014","journal-title":"J Pediatr Orthop B"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.thromres.2004.12.018","article-title":"Thrombolytic therapy in children","volume":"118","author":"Albisetti","year":"2006","journal-title":"Thromb Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1182\/blood-2006-12-061234","article-title":"A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children","volume":"110","author":"Goldenberg","year":"2007","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3760\/cma.j.issn.1673-4912.2019.03.004","article-title":"Advances in thrombolytic therapy for thrombosis-related diseases in children","volume":"3","author":"Ling","year":"2019","journal-title":"Chin Pediat Emerg Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0022-3476(05)82170-5","article-title":"Tissue plasminogen activator for the treatment of thromboembolism in infants and children","volume":"118","author":"Levy","year":"1991","journal-title":"J Pediatr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2165\/00128072-200103120-00002","article-title":"Management of preterm infants with intracardiac thrombi","volume":"3","author":"Rimensberger","year":"2001","journal-title":"Paediatr Drugs"},{"key":"B30","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0041-1740267","article-title":"Venous thromboembolism in premature neonates","volume":"48","author":"Fort","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1161\/STROKEAHA.123.042951","article-title":"Tenecteplase in acute stroke: what about the children?","volume":"54","author":"Sun","year":"2023","journal-title":"Stroke"},{"key":"B32","doi-asserted-by":"publisher","first-page":"344s","DOI":"10.1378\/chest.119.1_suppl.344S","article-title":"Antithrombotic therapy in children","volume":"119","author":"Monagle","year":"2001","journal-title":"Chest"},{"key":"B33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3760\/cma.j.issn.1007-9742.2004.06.122","article-title":"Knowledge of antithrombotic therapy (VIII): antithrombotic therapy in special situations\u2014children, patients with thrombophilia and various complex situations","volume":"6","author":"Bernd","year":"2004","journal-title":"Br Med J Chin Ed"},{"key":"B34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.blre.2018.06.003","article-title":"Are low-molecular-weight heparins safe and effective in children? A systematic review","volume":"33","author":"Klaassen","year":"2019","journal-title":"Blood Rev"},{"key":"B35","article-title":"FDA approves drug to treat, help prevent types of blood clots in certain pediatric populations","year":"2021"},{"key":"B36","article-title":"FDA approves first oral blood thinning medication for children","year":"2021"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e500","DOI":"10.1016\/S2352-3026(19)30161-9","article-title":"Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies","volume":"6","author":"Monagle","year":"2019","journal-title":"Lancet Haematol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1016\/S2352-3026(20)30368-9","article-title":"Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b\/3, non-inferiority trial","volume":"8","author":"Halton","year":"2021","journal-title":"Lancet Haematol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.23736\/S0026-4946.17.05131-3","article-title":"Antithrombotic treatment in neonates and children","volume":"70","author":"van Ommen","year":"2018","journal-title":"Minerva Pediatr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/MBC.0b013e328364f9b0","article-title":"Neonatal central venous catheter thrombosis","volume":"25","author":"Park","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.21037\/tp-22-529","article-title":"Risk factors for central venous catheter-related thrombosis in hospitalized children: a single-center a retrospective cohort study","volume":"11","author":"Li","year":"2022","journal-title":"Transl Pediatr"},{"key":"B42","volume-title":"Precision Anticoagulation Medicine: A Practical Guide","author":"Goubran","year":"2019"},{"key":"B43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/112972980700800404","article-title":"Primary thromboprophylaxis with heparins for arteriovenous fistula failure in pediatric patients","volume":"8","author":"Sharathkumar","year":"2007","journal-title":"J Vasc Access"},{"key":"B45","first-page":"56","article-title":"Optimizing the hemodialysis prescription and assessment of dialysis adequacy in children","volume":"5","author":"Hamsa","year":"2022","journal-title":"Asian J Pediatr Nephrol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/MOP.0000000000000894","article-title":"Renal replacement therapies for infants and children in the ICU","volume":"32","author":"Sanderson","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"B47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00467-015-3293-1","article-title":"Vitamin K antagonists in children with central venous catheter on chronic haemodialysis: a pilot study","volume":"31","author":"Paglialonga","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B48","first-page":"1010","article-title":"The efficacy and safety of argatroban in anticoagulation for hemodialysis in children","volume":"12","author":"Jin","year":"2011","journal-title":"Chin J IntegrNephrol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.13241\/j.cnki.pmb.2020.17.034","article-title":"Effect of argatroban anticoagulation on coagulation function and expression levels of TLR2rMnX and TLR4rMnX in monocytes of children with continuous blood purification","volume":"20","author":"Zhixian","year":"2020","journal-title":"Adv Modern Biomed"},{"key":"B50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00467-007-0658-0","article-title":"Central venous lines for chronic hemodialysis: survey of the midwest pediatric nephrology consortium","volume":"23","author":"Valentini","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/adc.2006.100065","article-title":"Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial","volume":"92","author":"Gittins","year":"2007","journal-title":"Arch Dis Child"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1055\/s-0038-1642635","article-title":"Catheter-related arterial thrombosis in neonates and children: a systematic review","volume":"118","author":"Rizzi","year":"2018","journal-title":"Thromb Haemost"},{"key":"B53","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jpeds.2021.08.035","article-title":"Treatment of catheter-related arterial thrombosis in children: a 15-year single- center experience","volume":"239","author":"Crameri","year":"2021","journal-title":"J Pediatr"},{"key":"B54","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/CIRCULATIONAHA.120.045597","article-title":"Fontan-associated liver disease","volume":"142","author":"Emamaullee","year":"2020","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/pcsu.2002.29716","article-title":"Thromboembolic problems after the fontan operation","volume":"5","author":"Monagle","year":"2002","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu"},{"key":"B56","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jacc.2011.01.061","article-title":"A multicenter, randomized trial comparing heparin\/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the fontan procedure in children","volume":"58","author":"Monagle","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jacc.2012.08.1023","article-title":"Factors associated with thrombotic complications after the fontan procedure","volume":"61","author":"McCrindle","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1016\/j.ijcard.2013.06.058","article-title":"Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and fontan palliation","volume":"168","author":"Potter","year":"2013","journal-title":"Int J Cardiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ahj.2019.04.009","article-title":"Rivaroxaban, a direct factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-fontan procedure: rationale and design of a prospective, randomized trial (the UNIVERSE study)","volume":"213","author":"Pina","year":"2019","journal-title":"Am Heart J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e021765","DOI":"10.1161\/JAHA.120.021765","article-title":"Thromboprophylaxis for children post-fontan procedure: insights from the UNIVERSE study","volume":"10","author":"McCrindle","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B61","article-title":"XARELTO\u00ae (rivaroxaban) prescribing information","author":"Janssen Pharmaceuticals","year":"2011"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jtcvs.2020.12.102","article-title":"Long-term outcomes of warfarin versus aspirin after fontan surgery","volume":"162","author":"Attard","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.thromres.2018.11.019","article-title":"Bleeding and thrombotic events occur early in children on durable ventricular assist devices","volume":"173","author":"Huang","year":"2019","journal-title":"Thromb Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.thromres.2018.02.145","article-title":"Antithrombotic therapies in children on durable ventricular assist devices: a literature review","volume":"172","author":"Huang","year":"2018","journal-title":"Thromb Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/0391398818773040","article-title":"Antithrombotic therapy in pediatric ventricular assist devices: multicenter survey of the European EXCOR pediatric investigator group","volume":"41","author":"Miera","year":"2018","journal-title":"Int J Artif Organs"},{"key":"B66","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/MAT.0000000000001093","article-title":"Utilization and outcomes of children treated with direct thrombin inhibitors on paracorporeal ventricular assist device support","volume":"66","author":"VanderPluym","year":"2020","journal-title":"ASAIO Journal"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1097\/MAT.0000000000001921","article-title":"Bivalirudin compared to heparin as the primary anticoagulant in pediatric Berlin heart recipients","volume":"69","author":"Freniere","year":"2023","journal-title":"ASAIO Journal"},{"key":"B68","article-title":"Modified blalock-taussig-thomas shunt","volume-title":"StatPearls","author":"Alahmadi","year":"2024"},{"key":"B69","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1177\/1076029616679506","article-title":"Incidence and management of thrombotic and thromboembolic complications following the Norwood procedure: a systematic review","volume":"23","author":"Agarwal","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1056\/NEJMoa1114588","article-title":"Clopidogrel in infants with systemic-to-pulmonary-artery shunts","volume":"368","author":"Wessel","year":"2013","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.athoracsur.2015.02.026","article-title":"Aspirin resistance in single-ventricle physiology: aspirin prophylaxis is not adequate to inhibit platelets in the immediate postoperative period","volume":"99","author":"Mir","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.jtcvs.2017.06.031","article-title":"Platelet testing to guide aspirin dose adjustment in pediatric patients after cardiac surgery","volume":"154","author":"Emani","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B73","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00246-016-1529-x","article-title":"Platelet inhibition in shunted infants on aspirin at short and midterm follow-up","volume":"38","author":"Truong","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1017\/S1047951118002536","article-title":"High acetylsalicylic acid dosing in infants after modified blalock-taussig shunt","volume":"29","author":"Saini","year":"2019","journal-title":"Cardiol Young"},{"key":"B75","first-page":"979","article-title":"Chinese expert consensus on the surgical treatment of congenital heart disease (VIII): single ventricle physiologic correction series of surgeries","volume":"27","author":"Zhongdong","year":"2020","journal-title":"Chin Clin J Thorac Cardiovasc Surg"},{"key":"B76","first-page":"33","article-title":"Peripheral vascular complications of cardiac catheterization","volume":"3","author":"Bin","year":"2002","journal-title":"Chin J Intervent Cardiol"},{"key":"B77","first-page":"670","article-title":"Analysis of risk factors for complications associated with vascular puncture for cardiac catheterization in children","volume":"39","author":"Yibei","year":"2021","journal-title":"J Clin Pediatr"},{"key":"B78","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/01.CIR.50.3.565","article-title":"The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children","volume":"50","author":"Freed","year":"1974","journal-title":"Circulation"},{"key":"B79","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1017\/S1047951114000171","article-title":"Post-catheterisation arterial thrombosis in children\u2013pathophysiology, prevention, and treatment","volume":"24","author":"Silva Marques","year":"2014","journal-title":"Cardiol Young"},{"key":"B80","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/021849230201000208","article-title":"Arterial complications following cardiac catheterization in children less than 10kg","volume":"10","author":"Bulbul","year":"2002","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"B81","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1017\/S104795110999103X","article-title":"Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children\u2014the HEARTCAT study","volume":"20","author":"Hanslik","year":"2010","journal-title":"Cardiol Young"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1111\/j.1538-7836.2011.04539.x","article-title":"Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high-dose vs. Low-dose heparin protocols","volume":"9","author":"Hanslik","year":"2011","journal-title":"J Thromb Haemost"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1182\/blood-2015-06-651661","article-title":"Monitoring unfractionated heparin in children: a parallel-cohort randomized controlled trial comparing 2 dose protocols","volume":"126","author":"Hanslik","year":"2015","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","first-page":"Cd010196","DOI":"10.1002\/14651858.CD010196.pub3","article-title":"Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization","volume":"2","author":"Avila","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1161\/01.cir.0000436140.77832.7a","article-title":"Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association","volume":"128","author":"Giglia","year":"2013","journal-title":"Circulation"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.13699\/j.cnki.1001-6821.2021.21.032","article-title":"2021 guidelines on the selection of anticoagulants and pharmacological monitoring for the prevention and treatment of venous thromboembolism in China","volume":"37","author":"Qiaoyu","year":"2021","journal-title":"Chin J Clin Pharmacol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/BPO.0000000000000391","article-title":"Incidence of deep vein thrombosis and pulmonary embolism in the elective pediatric orthopaedic patient","volume":"36","author":"Georgopoulos","year":"2016","journal-title":"J Pediatr Orthop"},{"key":"B88","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11832-015-0697-1","article-title":"Pediatric orthopaedic lower extremity trauma and venous thromboembolism","volume":"9","author":"Murphy","year":"2015","journal-title":"J Child Orthop"},{"key":"B89","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/BPO.0b013e31824b2a07","article-title":"The role of clinically significant venous thromboembolism and thromboprophylaxis in pediatric patients with pelvic or femoral fractures","volume":"32","author":"Greenwald","year":"2012","journal-title":"J Pediatr Orthop"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e000084","DOI":"10.1136\/wjps-2019-000084","article-title":"Venous thromboembolism in children undergoing surgery: incidence, risk factors and related adverse events","volume":"3","author":"Mets","year":"2020","journal-title":"World J Pediatr Surg"},{"key":"B91","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.otsr.2019.05.026","article-title":"Thrombotic risk in children undergoing orthopedic surgery","volume":"106","author":"Odent","year":"2020","journal-title":"Orthop Traumatol Surg Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1460-9592.2008.02597.x","article-title":"Perioperative thromboprophylaxis in children: development of a guideline for management","volume":"18","author":"Jackson","year":"2008","journal-title":"Paediatr Anaesth"},{"key":"B93","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/pan.13355","article-title":"Prevention of perioperative venous thromboembolism in pediatric patients: guidelines from the association of paediatric anaesthetists of Great Britain and Ireland (APAGBI)","volume":"28","author":"Morgan","year":"2018","journal-title":"Paediatr Anaesth"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e20.00194","DOI":"10.2106\/JBJS.RVW.20.00194","article-title":"Effects of anticoagulant medication on bone-healing","volume":"9","author":"Butler","year":"2021","journal-title":"JBJS Rev"},{"key":"B95","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tmrv.2017.10.001","article-title":"Purpura fulminans: mechanism and management of dysregulated hemostasis","volume":"32","author":"Colling","year":"2018","journal-title":"Transfus Med Rev"},{"key":"B96","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/14767058.2017.1285892","article-title":"Incidences, risk factors and outcomes of neonatal thromboembolism","volume":"31","author":"Sirachainan","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/j.1365-2516.2008.01838.x","article-title":"Protein C deficiency","volume":"14","author":"Goldenberg","year":"2008","journal-title":"Haemophilia"},{"key":"B98","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1182\/bloodadvances.2017012047","article-title":"Rivaroxaban dose adjustment using thrombin generation in severe congenital protein C deficiency and warfarin-induced skin necrosis","volume":"2","author":"Menon","year":"2018","journal-title":"Blood Adv"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e27686","DOI":"10.1002\/pbc.27686","article-title":"Management of severe congenital protein C deficiency with a direct oral anticoagulant, edoxaban: a case report","volume":"66","author":"Watanabe","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B100","first-page":"18","article-title":"Oral anticoagulant treatment of severe protein C deficiency in hereditary compound heterozygous mutations with neonatal fulminant purpura or intracranial hemorrhage as the first manifestation of severe protein C deficiency: a case report of two cases and review of the literature","volume":"17","author":"Yuqin","year":"2022","journal-title":"Chin J Evid Based Pediatr"},{"key":"B101","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"B102","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/MPG.0b013e3182801e43","article-title":"Venous thrombotic events in hospitalized children and adolescents with inflammatory bowel disease","volume":"56","author":"Nylund","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B103","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/MPG.0b013e31829ce5cd","article-title":"Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease","volume":"57","author":"Zitomersky","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B104","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jpeds.2018.02.039","article-title":"Catheter-related venous thrombosis in hospitalized pediatric patients with inflammatory bowel disease: incidence, characteristics, and role of anticoagulant thromboprophylaxis with enoxaparin","volume":"198","author":"Diamond","year":"2018","journal-title":"J Pediatr"},{"key":"B105","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ibd\/izy298","article-title":"Thrombotic and infectious risks of parenteral nutrition in hospitalized pediatric inflammatory bowel disease","volume":"25","author":"Egberg","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jss.2019.04.087","article-title":"Risk factors for venous thromboembolism in children and young adults with inflammatory bowel disease","volume":"243","author":"McKie","year":"2019","journal-title":"J Surg Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian association of gastroenterology","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/MPG.0000000000002036","article-title":"Management of paediatric ulcerative colitis, part 2: acute severe colitis-an evidence-based consensus guideline from the European crohn\u2019s and colitis organization and the European society of paediatric gastroenterology, hepatology and nutrition","volume":"67","author":"Turner","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3760\/cma.j.cn112140-20210905-00743","article-title":"Guidelines for the diagnosis and treatment of systemic lupus erythematosus in Chinese children","volume":"12","year":"2021","journal-title":"Chin J Pediatr"},{"key":"B110","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3760\/cma.j.cn101070-20220321-00295","article-title":"Expert consensus on clinical diagnosis and treatment of systemic lupus erythematosus in children (2022 edition)","volume":"37","year":"2022","journal-title":"Chin J Pract Pediatr"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1136\/annrheumdis-2016-211001","article-title":"European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B113","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.autrev.2013.10.014","article-title":"Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis","volume":"13","author":"Arnaud","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B114","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.autrev.2014.10.019","article-title":"Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies","volume":"14","author":"Arnaud","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B115","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid-antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e1100","DOI":"10.1542\/peds.2008-1209","article-title":"Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry","volume":"122","author":"Avcin","year":"2008","journal-title":"Pediatrics"},{"key":"B117","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/0961203306074767","article-title":"Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients","volume":"16","author":"Tarr","year":"2007","journal-title":"Lupus"},{"key":"B118","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/0961203307084724","article-title":"Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients","volume":"17","author":"Hereng","year":"2008","journal-title":"Lupus"},{"key":"B119","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"Tektonidou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.55563\/clinexprheumatol\/kn8hco","article-title":"Clinical characteristics of cerebral venous sinus thrombosis in childhood-onset systemic lupus erythematosus patients: a single-centre study from China","volume":"39","author":"Deng","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.revmed.2023.08.004","article-title":"French national diagnostic and care protocol for antiphospholipid syndrome in adults and children","volume":"44","author":"Amoura","year":"2023","journal-title":"Rev Med Interne"},{"key":"B122","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/MBC.0b013e32835bfd85","article-title":"Thrombosis and embolism in pediatric cardiomyopathy","volume":"24","author":"Chen","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B123","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3760\/cma.j.cn112140-20200619-00737","article-title":"Recommendations for the diagnosis and treatment of heart failure in children (2020 revision)","volume":"2","year":"2021","journal-title":"Chin J Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1519517\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T14:08:11Z","timestamp":1738850891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1519517\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":123,"alternative-id":["10.3389\/fped.2025.1519517"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1519517","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"article-number":"1519517"}}